Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of acute leukemia.
Lechner K, Geissler K, Jäger U, Greinix H, Kalhs P. Lechner K, et al. Among authors: kalhs p. Ann Oncol. 1999;10 Suppl 6:45-51. Ann Oncol. 1999. PMID: 10676552 Review.
Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reaction.
Mitterbauer G, Nemeth P, Wacha S, Cross NC, Schwarzinger I, Jaeger U, Geissler K, Greinix HT, Kalhs P, Lechner K, Mannhalter C. Mitterbauer G, et al. Among authors: kalhs p. Br J Haematol. 1999 Sep;106(3):634-43. doi: 10.1046/j.1365-2141.1999.01605.x. Br J Haematol. 1999. PMID: 10468851 Free article.
Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemia.
Greinix HT, Loidolt H, Rabitsch W, Schulenburg A, Keil F, Mitterbauer M, Laczika K, Lechner K, Dieckmann K, Fischer G, Jäger U, Rosenmayr A, Knöbl P, Schwarzinger I, Höcker P, Mannhalter C, Hinterberger W, Haas OA, Fonatsch C, Kalhs P. Greinix HT, et al. Among authors: kalhs p. Ann Hematol. 2000 Apr;79(4):206-13. doi: 10.1007/s002770050580. Ann Hematol. 2000. PMID: 10834508 Clinical Trial.
Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants.
Keil F, Prinz E, Kalhs P, Lechner K, Moser K, Schwarzinger I, Jäger U, Fonatsch C, Worel N, Mannhalter C, Rabitsch W, Loidolt H, Schulenburg A, Mitterbauer M, Höcker P, Greinix HT. Keil F, et al. Among authors: kalhs p. Leukemia. 2001 Mar;15(3):355-61. doi: 10.1038/sj.leu.2402048. Leukemia. 2001. PMID: 11237057
167 results